Investment Analysts’ Recent Ratings Changes for Robinhood Markets (HOOD)
A number of research firms have changed their ratings and price targets for Robinhood Markets (NASDAQ: HOOD): 10/21/2026 – Robinhood Markets had its price target raised by Needham & Company LLC from $123.00 to $126.00. They now have a “buy” rating on the stock. 10/21/2026 – Robinhood Markets is now covered by Rosenblatt Securities. They […]
Pacira BioSciences (PCRX) – Investment Analysts’ Weekly Ratings Changes
Several analysts have recently updated their ratings and price targets for Pacira BioSciences (NASDAQ: PCRX): 10/9/2026 – Pacira BioSciences was downgraded by Truist Financial Corporation from “buy” to “hold”. They now have a $36.50 price target on the stock, up from $31.00. 10/9/2026 – Pacira BioSciences had its price target raised by Royal Bank Of […]
Weekly Investment Analysts’ Ratings Changes for Magnolia Oil & Gas (MGY)
Magnolia Oil & Gas (NYSE: MGY) has recently received a number of price target changes and ratings updates: 10/17/2026 – Magnolia Oil & Gas was downgraded by Wall Street Zen from “buy” to “hold”. 10/15/2026 – Magnolia Oil & Gas was given a new $35.00 price target by UBS Group AG. 10/14/2026 – Magnolia Oil […]
Weekly Investment Analysts’ Ratings Changes for Cummins (CMI)
A number of research firms have changed their ratings and price targets for Cummins (NYSE: CMI): 10/19/2026 – Cummins had its price target lowered by Barclays PLC from $760.00 to $675.00. They now have an “overweight” rating on the stock. 10/17/2026 – Cummins was downgraded by Wall Street Zen from “buy” to “hold”. 10/12/2026 – […]
Investment Analysts’ Weekly Ratings Changes for Brookfield Renewable Partners (BEP)
Brookfield Renewable Partners (NYSE: BEP) recently received a number of ratings updates from brokerages and research firms: 10/19/2026 – Brookfield Renewable Partners had its price target lowered by JPMorgan Chase & Co. from $36.00 to $32.00. They now have a “neutral” rating on the stock. 10/13/2026 – Brookfield Renewable Partners had its price target lowered […]
TELUS (T) – Investment Analysts’ Recent Ratings Changes
A number of firms have modified their ratings and price targets on shares of TELUS (TSE: T) recently: 10/20/2026 – TELUS had its price target lowered by Scotiabank from C$17.00 to C$15.25. They now have a “sector perform” rating on the stock. 10/19/2026 – TELUS had its price target lowered by ATB Cormark Capital Markets […]
Investment Analysts’ Recent Ratings Changes for Element Solutions (ESI)
A number of research firms have changed their ratings and price targets for Element Solutions (NYSE: ESI): 10/12/2026 – Element Solutions is now covered by Barclays PLC. They set an “overweight” rating and a $53.00 price target on the stock. 10/12/2026 – Element Solutions was upgraded by Barclays PLC to “strong-buy”. 10/5/2026 – Element Solutions […]
Weekly Investment Analysts’ Ratings Changes for Conagra Brands (CAG)
Conagra Brands (NYSE: CAG) has recently received a number of price target changes and ratings updates: 10/2/2026 – Conagra Brands had its price target lowered by Barclays PLC from $17.00 to $16.00. They now have an “overweight” rating on the stock. 10/1/2026 – Conagra Brands was upgraded by Zacks Research from “strong sell” to “hold”. […]
AutoNation (AN) – Investment Analysts’ Weekly Ratings Changes
Several analysts have recently updated their ratings and price targets for AutoNation (NYSE: AN): 10/7/2026 – AutoNation had its price target lowered by UBS Group AG from $248.00 to $213.00. They now have a “buy” rating on the stock. 10/6/2026 – AutoNation had its price target lowered by Barclays PLC from $260.00 to $230.00. They […]
Weekly Investment Analysts’ Ratings Changes for C3.ai (AI)
C3.ai (NYSE: AI) has recently received a number of price target changes and ratings updates: 10/12/2026 – C3.ai was given a new $16.00 price target by Northland Securities. They now have an “outperform” rating on the stock. 10/12/2026 – C3.ai was upgraded by Northland Securities from “market perform” to “outperform”. They now have a $16.00 […]
PTC Therapeutics (PTCT) – Investment Analysts’ Weekly Ratings Changes
PTC Therapeutics (NASDAQ: PTCT) has recently received a number of price target changes and ratings updates: 10/16/2026 – PTC Therapeutics is now covered by Truist Financial Corporation. They set a “hold” rating and a $62.00 price target on the stock. 10/15/2026 – PTC Therapeutics had its “buy” rating reaffirmed by UBS Group AG. They now […]
Recent Investment Analysts’ Ratings Changes for Schrodinger (SDGR)
Several analysts have recently updated their ratings and price targets for Schrodinger (NASDAQ: SDGR): 10/16/2026 – Schrodinger had its price target raised by KeyCorp from $20.00 to $32.00. They now have an “overweight” rating on the stock. 10/13/2026 – Schrodinger had its price target raised by TD Cowen from $20.00 to $31.00. They now have […]
Dutch Bros (BROS) – Investment Analysts’ Weekly Ratings Changes
A number of firms have modified their ratings and price targets on shares of Dutch Bros (NYSE: BROS) recently: 10/15/2026 – Dutch Bros had its price target lowered by Stephens from $80.00 to $65.00. They now have an “overweight” rating on the stock. 10/15/2026 – Dutch Bros had its price target lowered by Morgan Stanley […]
Recent Analysts’ Ratings Changes for Gladstone Investment (GAIN)
Gladstone Investment (NASDAQ: GAIN) has recently received a number of price target changes and ratings updates: 10/12/2026 – Gladstone Investment was downgraded by Zacks Research from “strong-buy” to “hold”. 10/12/2026 – Gladstone Investment was upgraded by Wall Street Zen from “sell” to “hold”. 10/4/2026 – Gladstone Investment was downgraded by Wall Street Zen from “hold” […]
Recent Investment Analysts’ Ratings Changes for Repligen (RGEN)
Several brokerages have updated their recommendations and price targets on shares of Repligen (NASDAQ: RGEN) in the last few weeks: 10/8/2026 – Repligen was upgraded by Weiss Ratings from “hold (c-)” to “hold (c)”. 10/7/2026 – Repligen had its price target raised by Barclays PLC from $175.00 to $225.00. They now have an “overweight” rating […]
Recent Investment Analysts’ Ratings Changes for Kodiak Sciences (KOD)
A number of research firms have changed their ratings and price targets for Kodiak Sciences (NASDAQ: KOD): 10/12/2026 – Kodiak Sciences had its price target raised by HC Wainwright from $96.00 to $126.00. They now have a “buy” rating on the stock. 10/6/2026 – Kodiak Sciences was downgraded by Weiss Ratings from “sell (d-)” to […]
Investment Analysts’ Recent Ratings Changes for Rentokil Initial (RTO)
A number of research firms have changed their ratings and price targets for Rentokil Initial (NYSE: RTO): 10/13/2026 – Rentokil Initial was downgraded by Weiss Ratings from “hold (c-)” to “sell (d+)”. 10/5/2026 – Rentokil Initial had its “buy” rating reaffirmed by The Goldman Sachs Group, Inc.. 10/5/2026 – Rentokil Initial was upgraded by Stifel […]
Weekly Investment Analysts’ Ratings Changes for Bank of New York Mellon (BNY)
Bank of New York Mellon (NYSE: BNY) recently received a number of ratings updates from brokerages and research firms: 10/8/2026 – Bank of New York Mellon is now covered by TD Cowen. They set a “hold” rating and a $160.00 price target on the stock. 10/5/2026 – Bank of New York Mellon had its price […]
Weekly Investment Analysts’ Ratings Changes for MGM Resorts International (MGM)
MGM Resorts International (NYSE: MGM) recently received a number of ratings updates from brokerages and research firms: 10/13/2026 – MGM Resorts International was given a new $30.00 price target by The Goldman Sachs Group, Inc.. 10/12/2026 – MGM Resorts International had its price target lowered by Citigroup Inc. from $48.00 to $32.00. They now have […]
Investment Analysts’ Weekly Ratings Changes for Dell Technologies (DELL)
Dell Technologies (NYSE: DELL) has recently received a number of price target changes and ratings updates: 10/9/2026 – Dell Technologies had its “buy” rating reaffirmed by The Goldman Sachs Group, Inc.. 10/6/2026 – Dell Technologies had its price target raised by Mizuho from $600.00 to $650.00. They now have an “outperform” rating on the stock. […]
Weekly Investment Analysts’ Ratings Changes for Red Rock Resorts (RRR)
A number of firms have modified their ratings and price targets on shares of Red Rock Resorts (NASDAQ: RRR) recently: 10/12/2026 – Red Rock Resorts had its price target lowered by Citigroup Inc. from $78.00 to $69.00. They now have a “buy” rating on the stock. 10/9/2026 – Red Rock Resorts had its price target […]
Investment Analysts’ Weekly Ratings Changes for Apple (AAPL)
Apple (NASDAQ: AAPL) has recently received a number of price target changes and ratings updates: 10/12/2026 – Apple had its price target raised by JPMorgan Chase & Co. from $340.00 to $360.00. They now have an “overweight” rating on the stock. 10/8/2026 – Apple was upgraded by Weiss Ratings from “buy (b-)” to “buy (b)”. […]
Weekly Investment Analysts’ Ratings Changes for Seaport Therapeutics (SPTX)
Seaport Therapeutics (NASDAQ: SPTX) recently received a number of ratings updates from brokerages and research firms: 10/8/2026 – Seaport Therapeutics had its “buy” rating reaffirmed by UBS Group AG. 10/8/2026 – Seaport Therapeutics had its “buy” rating reaffirmed by HC Wainwright. They now have a $50.00 price target on the stock. 9/25/2026 – Seaport Therapeutics […]
Investment Analysts’ Weekly Ratings Changes for Monte Rosa Therapeutics (GLUE)
Several brokerages have updated their recommendations and price targets on shares of Monte Rosa Therapeutics (NASDAQ: GLUE) in the last few weeks: 10/5/2026 – Monte Rosa Therapeutics was given a new $25.00 price target by Raymond James Financial, Inc.. 10/5/2026 – Monte Rosa Therapeutics had its “buy” rating reaffirmed by Benchmark Co.. 10/1/2026 – Monte […]
Illinois Tool Works (ITW) – Investment Analysts’ Weekly Ratings Changes
A number of firms have modified their ratings and price targets on shares of Illinois Tool Works (NYSE: ITW) recently: 10/9/2026 – Illinois Tool Works was given a new $277.00 price target by UBS Group AG. 10/9/2026 – Illinois Tool Works was downgraded by JPMorgan Chase & Co. from “overweight” to “neutral”. They now have […]
Weekly Investment Analysts’ Ratings Changes for Beta Bionics (BBNX)
Beta Bionics (NASDAQ: BBNX) recently received a number of ratings updates from brokerages and research firms: 10/6/2026 – Beta Bionics is now covered by Barclays PLC. They set an “overweight” rating and a $30.00 price target on the stock. 10/6/2026 – Beta Bionics was upgraded by Barclays PLC to “strong-buy”. 9/24/2026 – Beta Bionics had […]
last updated on 23 Oct 07:40